KBio Holdings

KBio is a clinical-stage biotechnology company specializing in the development and production of biologics using a proprietary plant-based expression platform. Utilizing Nicotiana benthamiana plants, the company rapidly produces complex proteins, including vaccines and monoclonal antibodies, offering a scalable and cost-effective alternative to traditional mammalian cell culture. KBio's pipeline includes candidates for infectious diseases such as COVID-19 and seasonal influenza. The company also provides contract development and manufacturing services, leveraging its unique molecular farming technology to support global health initiatives. KBio operates as a subsidiary of British American Tobacco and is headquartered in Owensboro, Kentucky.